Literature DB >> 10585034

Blood product use in cardiac revascularization: comparison of on- and off-pump techniques.

N D Nader1, W Z Khadra, N T Reich, D R Bacon, T A Salerno, A L Panos.   

Abstract

BACKGROUND: Cardiac revascularization on a beating heart avoids the side effects of cardiopulmonary bypass (eg, neurologic injury, hemodilution, and coagulopathy). We examined perioperative bleeding and use of blood products during coronary artery bypass grafting using either on-pump or off-pump techniques.
METHOD: The charts of 126 patients who had coronary artery bypass grafting were reviewed. Data from 66 patients revascularized off pump and 60 patients with cardiopulmonary bypass (on pump) were analyzed using unpaired Student's t test.
RESULTS: Average age was 62.5 years in either group. More patients received heparin preoperatively in the off-pump group that resulted in mild elevation of preoperative partial thromboplastin time and activated clotting time (40.4 +/- 2.9 seconds and 150.1 +/- 5.3 seconds, respectively). However, the off-pump group had less perioperative (intraoperative or postoperative) bleeding (2312 +/- 212 mL versus 3251 +/- 155 mL, p < 0.05) and required fewer blood products compared with the on-pump group. Hemoglobin and platelets decreased more in the conventional on-pump group.
CONCLUSIONS: Avoiding cardiopulmonary bypass decreases perioperative bleeding and, consequently, reduces the use of blood products after coronary artery bypass grafting, which might result in fewer transfusion-related complications.

Entities:  

Mesh:

Year:  1999        PMID: 10585034     DOI: 10.1016/s0003-4975(99)00827-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

1.  Effects of half-dose aprotinin in off-pump coronary artery bypass grafting.

Authors:  Minxin Wei; Kaitao Jian; Zhipeng Guo; Peijun Li; Jiange Han; Zhong Cai; Matti Tarkka
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

Review 2.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  Ultra-minimally invasive cardiac surgery: robotic surgery and awake CABG.

Authors:  Norihiko Ishikawa; Go Watanabe
Journal:  Surg Today       Date:  2014-10-02       Impact factor: 2.549

Review 4.  Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients.

Authors:  Allyson M Pishko; Adam Cuker
Journal:  Semin Thromb Hemost       Date:  2017-06-08       Impact factor: 4.180

5.  Short-term complications and resource utilization in matched subjects after on-pump or off-pump primary isolated coronary artery bypass.

Authors:  Marilyn Hravnak; Leslie A Hoffman; Melissa I Saul; Thomas G Zullo; Julie F Cuneo; Ronald V Pellegrini
Journal:  Am J Crit Care       Date:  2004-11       Impact factor: 2.228

6.  Emergency off-pump coronary artery bypass grafting for acute left main coronary artery dissection.

Authors:  M Capdeville; J H Lee
Journal:  Tex Heart Inst J       Date:  2001

Review 7.  Heparin-induced thrombocytopenia: present and future.

Authors:  Adam Cuker
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

8.  Transfusion and bleeding in coronary artery bypass grafting: an on-pump versus off-pump comparison.

Authors:  Kieron C Potger; Darryl McMillan; Joanne Southwell; Terry Connolly; Kate Kingsford Smith; Mark Ambrose
Journal:  J Extra Corpor Technol       Date:  2007-03

9.  The impact of blood use on patients undergoing coronary artery bypass surgery: a prospective study.

Authors:  A Lako; S Bilali; S Memishaj; A Daka; T Dedej; T Nurka; V Bilali; V Gjylameti
Journal:  G Chir       Date:  2014 Jan-Feb

10.  Optimal anticoagulation during off pump coronary artery bypass in patients recently exposed to clopidogrel.

Authors:  Young Song; Jong Wook Song; Jae Kwang Shim; Young Lan Kwak
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.